Axa S.A. Mirati Therapeutics, Inc. Transaction History

Axa S.A.

  • $32.3 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$41.27 - $98.62 $1.19 Million - $2.84 Million
-28,824 Closed
0 $0
Q3 2022

Feb 14, 2023
BUY
$59.5 - $86.7 $8,032 - $11,704
135 Added 0.47%
28,824 $2.01 Million
Q3 2022

Nov 14, 2022
BUY
$59.5 - $86.7 $8,032 - $11,704
135 Added 0.47%
28,824 $2.01 Million
Q2 2022

Feb 14, 2023
SELL
$39.16 - $88.71 $21,577 - $48,879
-551 Reduced 1.88%
28,689 $1.93 Million
Q2 2022

Aug 15, 2022
SELL
$39.16 - $88.71 $21,577 - $48,879
-551 Reduced 1.88%
28,689 $1.93 Million
Q1 2022

Feb 14, 2023
BUY
$75.82 - $150.97 $31,541 - $62,803
416 Added 1.44%
29,240 $2.4 Million
Q1 2022

May 13, 2022
SELL
$75.82 - $150.97 $75 - $150
-1 Reduced -0.0%
29,240 $2.4 Million
Q4 2021

Feb 14, 2022
BUY
$132.01 - $190.29 $45,807 - $66,030
347 Added 1.2%
29,241 $4.29 Million
Q3 2021

Nov 15, 2021
BUY
$132.13 - $177.45 $141,775 - $190,403
1,073 Added 3.86%
28,894 $5.11 Million
Q2 2021

Aug 13, 2021
SELL
$144.0 - $179.73 $303,840 - $379,230
-2,110 Reduced 7.05%
27,821 $4.49 Million
Q1 2021

May 14, 2021
SELL
$158.92 - $221.61 $596,267 - $831,480
-3,752 Reduced 11.14%
29,931 $5.13 Million
Q4 2020

Feb 12, 2021
BUY
$162.05 - $240.27 $191,543 - $283,999
1,182 Added 3.64%
33,683 $7.4 Million
Q3 2020

Nov 13, 2020
SELL
$113.26 - $167.27 $34,204 - $50,515
-302 Reduced 0.92%
32,501 $5.4 Million
Q2 2020

Aug 14, 2020
BUY
$72.01 - $120.39 $401,167 - $670,692
5,571 Added 20.46%
32,803 $3.75 Million
Q1 2020

May 15, 2020
SELL
$69.78 - $116.21 $126,929 - $211,385
-1,819 Reduced 6.26%
27,232 $2.09 Million
Q4 2019

Feb 18, 2020
BUY
$70.76 - $128.86 $51,230 - $93,294
724 Added 2.56%
29,051 $3.74 Million
Q3 2019

Nov 14, 2019
SELL
$77.91 - $109.6 $3,350 - $4,712
-43 Reduced 0.15%
28,327 $2.21 Million
Q2 2019

Aug 13, 2019
BUY
$59.49 - $104.71 $1.69 Million - $2.97 Million
28,370 New
28,370 $2.92 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email